EVALUATING AND PRESENTING BIOTECH COMPANIES TO INVESTORS 

Prof. Baruch Lev, Dr. Edna Pasher, Mati Gil and Dr. Boaz Tadmor
Overcoming the severe deficiencies of the accounting system :
How the outdated accounting system has rendered financial reports of biotech and intangibles-intensive companies largely irrelevant and misleading, hindering their growth potential and investor confidence.